*Jeremiah 33:6 *'Nevertheless, I will bring health and healing to it; I will heal my people and will let them enjoy abundant peace and security.
|
|
- William Bridges
- 5 years ago
- Views:
Transcription
1 Jeremiah 33:6 Ministry FAITH and HEALTH TEACHING CONNECTION 2 nd Saturdays 10am West Fellowship Hall Brian Mitu, NP, PA-C Nurse Practitioner/Physician Asst. - St. Albert Medical Clinic Eliza Rivera-Mitu, MSN, APRN, FNP-C Professor El Camino College/Compton College/Samuel Merritt University; Cardiac Stress Test Nurse Practitioner St. Albert Medical Clinic Jeremiah 33:6 'Nevertheless, I will bring health and healing to it; I will heal my people and will let them enjoy abundant peace and security. Hosea 4:6 My people are destroyed for lack of knowledge 1
2 To reach people, serve our community and let them know that our Lord Jesus Christ loves them through educating them about their health and how to improve it for God s glory. At the end of each life group session, the participants will be able to: 1. Realize the miracle of life that God has given us by learning about the Anatomy and Physiology of the human body. 2. Gain knowledge about prevention and management of chronic diseases. 3. Prevent chronic diseases through lifestyle change for the glory of God. 2
3 At the end of each life group session, the participants will be able to: 4. Realize that our body is the temple of God, and therefore should be kept holy and clean. 5. Maintain optimum health through total lifestyle change in order to serve God wholly and fully. 6. Educate and enlighten others about the new knowledge that are gained, therefore also spreading the Word of God. Incidence of diabetes is growing rapidly both in the US and worldwide Over 180 million people worldwide are afflicted Prevalence is expected to more than double by year 2030 USA, approximately 21 million are estimated to suffer from diabetes, and is the major cause of morbidity and mortality 3
4 Diabetes is known as starvation in a midst of plenty. It is characterized by an increase of blood glucose by relative or absolute deficiency of insulin, insulin resistance 4
5 5
6 Type 1 (formerly known as insulindependent DM) Type 2 (formerly known as non-insulin dependent DM) Gestational DM Carbohydrate intolerance with onset or 1 st recognition during pregnancy Diabetes due to other causes Medication induced Cause Autoimmune destruction of beta cells Represents 5-10% of diabetics Characteristics Age: less than 20 years old; Onset: Weeks Insulin secretion: falling to none; thus, Insulin is the only treatment Body image: lean Acute complication: Diabetes ketoacidosis Microvascular complications at DX: no Macrovascular complications at DX: uncommon 6
7 Cause Decrease in beta cells activity (insulin deficiency) Insulin resistance ( uptake of insulin by peripheral muscle cells) Increase glucose production by the liver Represents: 90-95% of diabetics Characteristics Age: over 40year old; Onset: gradual ( Takes about 10 years before diagnosis) Insulin secretion: oversecretion for years Body image: overweight or obese Insulin required for treatment: No Acute complication : Hyperosmolar Non-Ketoacidosis Microvascular complication at diagnosis: common Macrovascular complication at diagnosis: common 7
8 8
9 Before eating (Fasting state) blood glucose: Normal Before eating blood glucose: Impaired fasting (borderline diabetic) Before eating blood glucose: > 126 Diabetic Non-fasting blood glucose > 200 plus symptoms diabetic 2 hour Oral glucose tolerance test diabetic Hemoglobin A1C > 6.5 diabetic 9
10 To maintain Blood glucose concentrations with in the normal limits and to prevent the development of long term complications of the disease Microvascular complications Destruction of capillaries in eyes, kidneys, peripheral tissues Macrovascular complications Artherosclerosis of middle to large arteries such as the heart and brain 10
11 Diabetic Retinopathy: It is the leading cause of blindness among U.S. adults. Diabetes can damage the retina; this is the nerve tissue at the back of the eye. This tissue is sensitive to light. And, it sends visual images to the brain. Changes in the tiny blood vessels that send blood here cause eye damage. 11
12 12
13 Diabetic retinopathy stages Nonproliferative Retinopathy (EARLY) Blood vessels of the retina get weak and develop bulges (called microaneurysms ) These may leak blood (hemorrhage), or they may leak fluid into the tissue around the retina Proliferative Retinopathy (Late) New, fragile blood vessels start to grow on the retina and into a jelly-like substance inside the back of the eye These abnormal vessels are prone to rupture and bleed into the back of the eye 13
14 Studies show that keeping blood sugar in control can: Reduce how many people develop eye damage Prevent eye damage from getting worse. If you get eye disease, laser surgery can treat it. And, vision can be preserved if the eye damage is found early. About half of those who do not get treated will become blind in 5 years. But, only 5% who do get treated may become blind. Routine eye exams are key; this is the best way to detect eye damage in its treatable stages. Nephropathy Kidney disease develops in about: 1 out of 3 people with type 1 diabetes 1 out of 5 people with type 2 diabetes. This disease can lead to kidney failure. The number of people who get kidney disease is going down, though. This is because we now know that tight control of blood sugar can help. It cuts the risk of kidney damage in half. And, use of medicine ( ACE inhibitors ) can help stop kidney damage. 14
15 Coronary heart disease Arteries that carry blood to the heart can get narrow which can lead to Chest pain (Angina) or Heart Attack (Myocardial infarction) People who have diabetes are at risk for Coronary Heart Disease. Women who have diabetes are at high risk for heart attacks. The arteries to the heart tend to get wider when you exercise.this increases blood flow to the heart. Other risk factors: Smoking, high blood pressure, high LDL ( bad ) cholesterol, low HDL ( good ) cholesterol 15
16 Stroke People who have diabetes are at risk for stroke. Stroke risk factors that are related to diabetes include: High A1C levels (high blood sugar); Long history of diabetes High blood sugar may raise stroke risk in different ways. It may: Allow cholesterol to build up faster along arteries to the brain, promote blood clots Another risk factor for stroke is high blood pressure. Many people with diabetes have high blood pressure. 16
17 Poor circulation of blood to the feet (called peripheral vascular disease ). Cold feet can be a sign of poor circulation Also, pain in your legs when you walk or exercise. But, that pain stops as soon as you rest. If so, this is a special condition (called intermittent claudication ). Exercise is a good treatment for poor circulation; it helps new blood vessels grow 17
18 18
19 Loss of feeling in the feet (from peripheral neuropathy ). These lead to Amputation. Check for numbness yourself. 19
20 Do you not know that your bodies are temples of the Holy Spirit, who is in you, whom you have received from God? You are not your own; you were bought at a price. Therefore honor God with your bodies. Do you not know that you are God s temple and that God s Spirit dwells in you? If anyone destroys God s temple, God will destroy him. For God s temple is holy, and you are that temple. 20
21 Lifestyle modification: Weight reduction, Exercise, Dietary modification Treat co-morbid condition Medications oral, injectable or Insulin 21
22 1 Corinthians 9:27(NLT) I discipline my body like an athlete, training it to do what it should. Exercise can help you improve your blood sugar control, boost your overall fitness, and reduce your risk of heart disease and stroke. Check your Blood Sugar before exercise Lower than 100. Your blood sugar may be too low to exercise safely. Eat a small snack containing 15 to 30 grams of carbohydrates, such as fruit juice, fruit, crackers or even glucose tablets before you begin your workout. 100 to 250. You're good to go. For most people, this is a safe pre-exercise blood sugar range Types of exercise Walking (split three 10 minute fast walk per day) Walk the dog, Park car at a distance, take the stairs instead of elevator, Yard work w/ push mower Family biking, soccer w/ kids, Swim with family Jogging, Hiking, Dance, elliptical Yoga and Tai chi 22
23 Daniel 1: Please test us for ten days on a diet of vegetables and water, Daniel said. 13 At the end of the ten days, see how we look compared to the other young men who are eating the king s food Know your good carbohydrates (low to medium glycemic Index) 100% stone-ground whole wheat or pumpernickel bread, Whole Wheat pasta/bread, asparagus, cauliflower, Ezekiel bread, Skim milk Apple or Berries: Black, Raspberry, Strawberry, Blue Berry Rolled or steel-cut oatmeal, oat bran, muesli Sweet potato, corn, yam, lima/butter beans, peas, legumes, lentils, SQUASH, Acorn, Butternut, pumpkin Brown, wild or basmati rice, couscous,quinoa, Bulgur, Greek Yogurt Bad carbohydrates (High glycemic index) White bread, bagel, corn flakes, puffed rice, bran flakes, instant oatmeal, flour, sugar Rice pasta, white rice, macaroni and cheese White/Russet potato, pumpkin Pretzels, rice cakes, pop corn, saltine crackers Melon, pineapple, raisins, Bananas, grapes 23
24 Portion and frequency of meals Eat 5 to 6 times per days (small portion) Carbohydrates 3 ounces per meal 4 ounces of protein (Women); 6 ounces of protein (Men) Avoid dairy products A more detailed diet and meal plan will be discussed in weight loss lecture 24
25 Self Blood Glucose Monitoring Before Eating: Two Hours after eating: Less Th 180 Bedtime (Make sure you have light Snack to avoid low blood sugar) A1C Goal Less than 7% if your over 65 years old Less than 6.5% if your less than 65 years old Baby Aspirin (81 mg) for Heart or Stroke prophylaxis Control Blood pressure Take your blood pressure medication regularly, ACE inhibitors ( ends w/ pril ) Lisinopril, benazepril, zestril, etc Blood Pressure goal: Less than 130/80 Control Cholesterol Take your cholesterol medication (ends w/ -statin ) Cholesterol level goal: HDL (good cholesterol) above 45 ; LDL (Bad cholesterol) below70 Triglyceride below 150; Total cholesterol below
26 Bathe your feet daily. Wash carefully with warm water and soap; rinse and dry thoroughly. Make sure you dry completely between the toes. Be careful as you trim your toenails. File straight across. Think about going to see a podiatrist; he or she can do your regular foot care. Do not use products for corn or callus removal; be sure never to try to trim calluses yourself. Try to figure out pressure points that might be causing a callus. Then, be sure to stop that pressure. See a foot doctor for treatment. 26
27 Moisturize feet that are dry. If the skin on your feet is dry, a moisturizing cream will help. But, you should apply it sparingly. Never apply it between the toes. Inspect your feet daily. Be on the lookout for: cuts; red spots, warm spots, or hot spots; calluses or corns; ingrown toenails; change in color; or any other abnormalities. Never go barefoot; always wear shoes to cover your feet. Make sure your shoes fit right. Shoes that are too tight can cause blisters and calluses; Shoes that are too loose can also cause ulcers or blisters as they rub against the foot. Make sure socks aren't rubbing, either. 27
28 PLEASE FILL OUT A CARD TO SUGGEST A TOPIC THAT YOU WOULD LIKE TO DISCUSS IN FUTURE MEETINGS 28
29 Biguanides Glucophage, Fortamet, Glumetza (metformin) Sodium-Glucose co-transporter 2 Inhibitors (SGLT-2 inhibtior) Jardiance (empagliflozin), Farxiga (dapagliflozin), Invokana (canagliflozin) Combination: Invokanamet (canagliflzin/metformin), Glyxambi (empagliflozin/linagliptin), Synjardy (empagliflozin), Xigduo (dapagliflozin/metformin), Qtern (dapagliflozin/saxagliptin) Incretin-Mimetic Agent ( Non-insulin injectables) Byetta (exenatide), Victoza (liraglutide) daily Bydureon BCise (exenatide), Trulicity (dulaglutide) once weekly Dipeptidyl peptidase-4 inhibitors Januvia (sitagliptin), Onglyza (saxagliptin), Tradjenta (linagliptin) 29
30 Secretagogues Sulfonylureas 1st generation:orinase (tolbutamide), Tolinase (tolazamide), Dymelor (acetohexamide), Diabense (chlorpropamide) 2nd generation: Glucotrol (glipizide), Micronase, Diabeta (glyburide), Amaryl (glimepiride) Meglitinide analogs Prandin (repaglinide), Starlix (nateglinide) Insulin Sensitizer Actos (pioglitazone), Avandia (rosiglitazone) Alpha glucosidase Inhibitors Precose (acarbose), Glyset (miglitol) Dopamine Agonist Cycloset, Parlodel (bromocriptine) Bile sequestrants Welchol (colesevelam) 30
31 Rapid Acting Novolog (aspart),humalog (lispro),apidra (glusine) Short Acting Humulin R (human);novolin R (human) Intermediate-Acting Insulin Humulin N (human),novolin N (human),lente iletin II (PORK) Basal Insulin Lantus(glargine);Levemir(detemir) Inhaled Insulin:Exubera (off market) ; Afrezza Glucophage, Fortamet, Glumetza (metformin) How they work: Improve insulin's ability to move sugar into cells (decrease insulin resistance), especially muscle cells. They also prevent the liver from releasing stored sugar (gluconeogenesis and glycogenolysis). Advantage: Weight loss; No risk of low blood sugar (Hypoglycemia) Side Effect: Diarrhea, Abdominal cramps 31
32 Glucophage, Fortamet, Glumetza (metformin) Contraindication You should not take them if you have kidney damage or heart failure Pts receiving radiopaque dyes. Radiopaque dyes often induce temporary Renal Insufficiency Stop metformin hours before procedures in which radiopaque dye will be administered Do not restart metformin for 2-3 days and until normal renal function has been proven Ethanol (Alcohol) Ethanol potentiates the effects of metformin on lactate metabolism Note: Long-term use may interfere with vitamin B12 absorption. Also use in women with PCOS (polycystic ovarian syndrome) 32
33 Jardiance (empagliflozin), Farxiga (dapagliflozin), Invokana (canagliflozin) Combination: Invokanamet,Glyxambi, Synjardy, Xigduo, Qtern How it works: blocks the reabsorption of glucose in the kidney, increase glucose excretion, and lower blood glucose levels 33
34 Side effects Weight loss, excessive urination leading dehydration (Drink plenty of fluids), genital yeast infection ( Meticulous perineal hygiene) Toe amputation with Invokana (canagliflozin) 34
35 Byetta (exenatide), Victoza (liraglutide) daily Bydureon BCise (exenatide), Trulicity (dulaglutide) once weekly How it works: Incretin is a natural hormone comes from L- cells located in the distal ileum and colon in response to ingestion of carbohydrates and fats. Incretin mimetics act like (mimic) the incretins in your body How it works Incretin helps decrease Blood sugar by Enhancing insulin release Suppressing glucagon secretion by the liver, Decreasing glucose output from the liver, Delaying gastric emptying which leads to feeling of fullness, delayed absorption of sugar and fat. As a result Weight loss, Maintaining pancreatic beta cell function Side effects: Nausea, Vomiting, Pancreatitis 35
36 Januvia (sitagliptin), Onglyza (saxagliptin), Tradjenta (linagliptin) How it works Inhibits the enzyme DDP4, which is responsible for the inaction of incretin hormones, such as glucagon-like peptide-1(glp-1) Prolongation of incretin activity results in increase insulin release in response to meals and reduction inappropriate secretion of glucagon Side Effect: Nasopharyngitis, Headache, Pancreatitis 1st generation: Orinase (tolbutamide), Tolinase (tolazamide), Dymelor (acetohexamide), Diabense (chlorpropamide) 2nd generation: Glucotrol (glipizide), Micronase, Diabeta (glyburide), Amaryl (glimepiride) How it works: Promote insulin release from B cells of the pancreas, decrease hepatic glucose production, increase peripheral insulin sensitivity (Do not skip meals) Side Effects: Weight gain, low blood sugar 36
37 Prandin (repaglinide), Starlix (nateglinide) How it works: Same action as sulfonylureas, but has a rapid onset of action and short duration span compared to sulfonylureas Side Effect: Hypoglycemia Note: due to shorter duration,must be taken 3 times per day (which leads to noncompliance) Actos (pioglitazone), Avandia (rosiglitazone) How it works Lowers Blood Glucose by increasing the sensitivity of muscle and fat tissue to insulin, allowing more glucose to enter the cells Inhibit hepatic gluconeogenesis and decrease hepatic glucose output Side Effect Liver toxicity. Stop medicine if Liver function test (LFTs) more than 3x the normal (Check baseline and 6 weeks after initiation) Weight gain due to increase SC fat or fluid retention (can lead to Heart Failure), osteopenia and risk Fracture 37
38 Precose (acarbose), Glyset (miglitol) How it works Block enzymes (pancreatic alpha amylase and GI alpha glucoside hydrolase) that help digest carbohydrates, slowing the rise in blood sugar Side Effect: Flatulence, Diarrhea, Abdominal cramps Contraindication: Inflammatory bowel disease (IBD), Colonic ulceration, Intestinal obstruction Cycloset, Parlodel (bromocriptine) How it works: Increases dopamine receptor activity in the morning, which lowers blood sugar without increasing insulin Not usually prescribed 38
39 Welchol (colesevelam) Used for lowering cholesterol How it works in lowering blood glucose is not known I personally don t prescribe this medication Released by the pancreas in a steady rate unit per hour. Ave units per days Insulin from pancreases different animals (pork, beef) have been used for years; however, due to increased incidence of allergic reaction; biosynthetic human insulin is now the most commonly used 39
40 Types of insulin Rapid acting Short acting (rarely used now) Intermediate acting (rarely used now) Long acting Rapid Acting Novolog (aspart), Humalog (lispro), Apidra (glusine) Onset of action: minutes Peak effect 1-3 hours Duration 6 hours Take less than 15 minutes before meals or immediately after meals Side effect: Hypoglycemia 40
41 Short Acting Humulin R (human); Novolin R (human) Onset: ½- 4hours Peak: 2 ½-5 hours Duration: 5-10hours Side effect: hypoglycemia Intermediate-Acting Insulin Humulin N (human), Novolin N (human), Lente iletin II (PORK) Onset: 1-2 hours Peak: 4-6 hours Duration: 12 hours Side effects: Hypoglycemia Combination insulin Humulin 70/30 or Novolin 70/30; Humalog 75/25; Novolog 70/30 41
42 Basal Insulin Lantus (glargine); Levemir (detemir) Mimics steady pancreatic release of insulin. Onset: 1 hour No Peak Duration: hours Newer kind: Tresiba (degludec); Toujeo (glargine) Basaglar (glargine) Combination: Ryzodeg (70% Tresiba 30% aspart); Xultophy (Tresiba and Victoza);Soliquia (glargine and lixisenatide) Exuber (Rapid acting insulin) This medication was pulled out of the market because of the required medical expense ($$$$$) needed before administration and throughout therapy I personally did not prescribed this medication because of the above reason; Furthermore, its not known about its possible effect on the lungs New version: AFREZZA 42
43 Do not freeze or be heated above 98 F (loss of potency) Store in refrigerator until opened Bottle can be kept at room temperature until gone F Open vial must be discarded in 30 days (not sterile) All insulin except regular, Novolog (aspart), Humalog (lispro), Apidra (glusine) Vial must be rolled in the palms of the hands to warm and resuspend the insulin (lost of potency, clumping, precipitation) Prefilled insulin syringes must be stored in refrigerator and in a vertical position with the needle up. Must be rolled gently between the hands 43
Objectives. How Medicine Works to Control Blood Sugar Levels. What Happens When We Eat? What is diabetes? High Blood Glucose (Hyperglycemia)
How Medicine Works to Control Blood Sugar Levels Stacie Petersen, RN, CDE Objectives Define Diabetes List how medications work (ominous octet) Identify side effects of medications for diabetes What is
More informationWhat the Pill Looks Like. How it Works. Slows carbohydrate absorption. Reduces amount of sugar made by the liver. Increases release of insulin
Diabetes s Oral s - Pills These are some of the pills that are currently available in Canada to treat diabetes. Each medication has benefits and side effects you should be aware of. Your diabetes team
More informationRPCC Pharmacy Forum. The Type 2 Diabetes Issue. Type 2 Diabetes: The Basics
Nov/Dec 2015 Issue 11 RPCC Pharmacy Forum Special Interest Articles: Diabetes Medication Chart Insulin Chart Afreeza Did you know? Exanatide, marketed as Byetta, is the synthetic form of exendin-4, which
More informationDiabetes Basics. Type 1 diabetes The body cannot make insulin Requires insulin injection Is not treated with oral diabetes medicines (pills)
Diabetes Basics What is Diabetes? Diabetes is a disease in which the pancreas is unable to make insulin or the body is unable to use insulin or both. This leads to high blood sugar levels in the blood.
More informationDiabetes Medications: Oral Anti-Hyperglycemic Medications
Diabetes Medications: Oral Anti-Hyperglycemic Medications Medication Types 1. Biguanides 2. Sulfonylureas 3. Thiazolidinediones (TZDs) 4. Alpha-Glucosidase Inhibitors 5. D-Phenylalanine Meglitinides 6.
More informationDiabetes Medication Updates Erica Bukovich, PharmD, BC-ADM, CDE September 20, 2018
Diabetes Medication Updates Erica Bukovich, PharmD, BC-ADM, CDE September 20, 2018 Learning Objectives Identify medication classes available for treatment of individuals with diabetes. Demonstrate understanding
More informationI. General Considerations
1 2 3 I. General Considerations A. Type I ( Juvenile Onset or IDDM) IDDM results from autoimmune destruction of beta cells inability to secrete insulin --> ketone formation --> DKA 4 Diabetic Ketoacidosis
More informationSociety for Ambulatory Anesthesia Consensus Statement on Perioperative Blood Glucose Management in Diabetic Patients Undergoing Ambulatory Surgery
Society for Ambulatory Anesthesia Consensus Statement on Perioperative Blood Glucose Management in Diabetic Patients Undergoing Ambulatory Surgery Girish P. Joshi, MB BS, MD, FFARCSI Anesthesia & Analgesia
More informationDIABETES. overview of pharmacologic agents used in the management of. Overview 4/3/2014 OBJECTIVES. Injectable Agents
overview of pharmacologic agents used in the management of DIABETES Kyle Roberts, Pharm.D. PGY-1 Pharmacy Resident Saint Alphonsus RMC 1. List the different classes of diabetes medications, including the
More informationPharmacology Updates. Quang T Nguyen, FACP, FACE, FTOS 11/18/17
Pharmacology Updates Quang T Nguyen, FACP, FACE, FTOS 11/18/17 14 Classes of Drugs Available for the Treatment of Type 2 DM in the USA ### Class A1c Reduction Hypoglycemia Weight Change Dosing (times/day)
More informationFARXIGA (dapagliflozin) Jardiance (empagliflozin) tablets. Synjardy (empagliflozin and metformin hydrochloride) tablets. GLUCOPHAGE* (metformin)
Type 2 Medications Drug Class How It Works Brand and Generic Names Manufacturers Usual Starting Dose The kidneys filter sugar and either absorb it back into your body for energy or remove it through your
More informationOral Medication for the Management of Diabetes Mechanism of. Duration of Daily Dosing Action
Glyburide (Micronase, Diabeta, Glynase) Glipizide (Glucotrol) Glipizide XL (Glucotrol XL) Glimepiride (Amaryl) Prandin (Repaglinide) Starlix (Nateglinide) 1.25, 2.5, 5mg tabs, Dosing: 2.5-20 mg 12- (Glynase:
More informationDiabetes Oral Agents Pharmacology. University of Hawai i Hilo Pre-Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D
Diabetes Oral Agents Pharmacology University of Hawai i Hilo Pre-Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D 1 Learning Objectives Understand the role of the utilization of free
More informationImages have been removed from the PowerPoint slides in this handout due to copyright restrictions. Insulins. Rapid Short Intermediate Long Mix
Diabetes Medications Diabetes Medications Type 1 Insulin is needed Type 2 Oral Diabetes Medications Or Oral Diabetes Medications plus Insulin Or Insulin Alone Diabetes Medications Secretagogues Glipizide
More information4/9/2018 HOW TO REGULATE DIABETES MEDICATIONS. By Sarah Froemsdorf MSN, RNC, CDE, FNP DISCLOSURES NONE. Diagnosis
HOW TO REGULATE DIABETES MEDICATIONS By Sarah Froemsdorf MSN, RNC, CDE, FNP DISCLOSURES NONE Diagnosis 1 NORMAL BODY The normal pancreas releases one unit of insulin every hour all day. The normal pancreas
More informationClinical Cases in Diabetes Management. Joseph Cook D.O.
Clinical Cases in Diabetes Management Joseph Cook D.O. Objectives State the prevalence of Diabetes Mellitus in Ohio State the percentage of diabetic patients in the U.S. treated by Primary Care Physicians
More informationDiabetes School October 2016
Diabetes School October 2016 Name Change- Why? Shorter Has my name in it Emphasizes a major part of the practice Still see non-research patients Novo Nordisk Lilly sanofi aventis! Thank You to our LucasResearch
More informationWhat s New in Diabetes Treatment. Disclosures
What s New in Diabetes Treatment Shiri Levy M.D. Henry Ford Hospital Senior Staff Physician Service Chief, West Bloomfield Hospital Endocrinology, Metabolism, Bone and Mineral Disorders Disclosures None
More informationType 2 Diabetes: Where Do We Start with Treatment? DIABETES EDUCATION. Diabetes Mellitus: Complications and Co-Morbid Conditions
Diabetes Mellitus: Complications and Co-Morbid Conditions ADA Guidelines for Glycemic Control: 2016 Retinopathy Between 2005-2008, 28.5% of patients with diabetes 40 years and older diagnosed with diabetic
More informationObjectives. Recognize all available medical treatment options for diabetes. Individualize treatment and glycemic target based on patient factors
No disclosure Objectives Recognize all available medical treatment options for diabetes Individualize treatment and glycemic target based on patient factors Should be able to switch to more affordable
More informationDiabetes Mellitus Type 2
Diabetes Mellitus Type 2 What is it? Diabetes is a common health problem in the U.S. and the world. In diabetes, the body does not use the food it digests well. It is hard for the body to use carbohydrates
More informationMultiple Small Feedings of the Mind: Diabetes. Sonja K Fredrickson, MD, BC-ADM March 7, 2014
Multiple Small Feedings of the Mind: Diabetes Sonja K Fredrickson, MD, BC-ADM March 7, 2014 Question 1: Setting A1c Goals Describe the evidence based approach to determining the target HgbA1c in different
More informationJonathan Stoehr, MD PhD Endocrinology, Diabetes, Metabolism and Nutrition Virginia Mason Medical Center Seattle, WA 2012 Virginia Mason Medical
Jonathan Stoehr, MD PhD Endocrinology, Diabetes, Metabolism and Nutrition Virginia Mason Medical Center Seattle, WA There is no conflict of interest that could be perceived as prejudicing the impartiality
More informationDiabetes Mellitus II CPG
1 Diabetes Mellitus II CPG Candidates for Screening Integrated Complex Care Patients: Check Yearly Prediabetes: Check Yearly No Diabetes Mellitus (DM) Risk Factors: Check at Age 45, Repeat Every 3 Years
More informationDiabetes Management: A diagnostic perspective
Diabetes Management: A diagnostic perspective Images: http://www.engadget.com/2009/09/23/bayer-introduces-countour-usb-glucose-meter/ http://www.medtronicdiabetes.com/treatment-and-products/minimed-530g-diabetes-system-with-enlite
More informationOral and Injectable Non-insulin Antihyperglycemic Agents
Appendix 5: Diabetes Education and Medical Management in Adults with Diabetes Oral and Injectable Non-insulin s This directive will be implemented by RPhs, RNs or RDs who have been deemed authorized implementers.
More information1/15/2018. Disclosures. Current Diabetes Medications. Objectives NON-INSULIN AGENTS. Diabetes Med Classes. Mealtime
Disclosures Current Diabetes Medications None Claire Baker, M.D. Diabetes & Endocrine Associates January 24, 2018 Objectives Identify categories of diabetes medications Understand the pharmacology of diabetes
More informationNon-Insulin Diabetes Medications Summary
Non-Insulin Diabetes Medications Summary Medications marked with an asterisk (*) can cause hypoglycemia INSULIN SECRETAGOGUES Sulfonylureas* GLYBURIDE* (Diabeta) (Micronase) production. Side effects: Potential
More informationDiabetes Treatment Guidelines
Diabetes Treatment Guidelines For more comprehensive information about current approaches to the diagnosis and treatment of diabetes, visit the American Diabetes Association Standards of Medical Care 2018
More informationGet Healthy Stay Healthy
Diabetes Management WHAT IS DIABETES? Diabetes is a lifelong disease. It is a defect in your body s ability to convert glucose (sugar) to energy. Diabetes develops when your pancreas does not produce enough
More informationTable 1. Antihyperglycemic agents for use in type 2 diabetes
Table 1. Antihyperglycemic agents for use in type 2 diabetes DRUG IN ALPHA-GLUCOSIDASE INHIBITOR: inhibits pancreatic alpha-amyle and intestinal alpha-glucoside Acarbose (Glucobay) 0.6% Negligible Not
More informationDiabetes Mellitus. Raja Nursing Instructor. Acknowledgement: Badil 09/03/2016
Diabetes Mellitus Raja Nursing Instructor 09/03/2016 Acknowledgement: Badil Objective: Define Diabetes Mellitus (DM) & types of DM. Understand the pathophysiology of Type-I & II DM. List the clinical features
More informationManagement of Type 2 Diabetes Mellitus. Heather Corn, MD, MS Endocrinology, Diabetes, and Metabolism
Management of Type 2 Diabetes Mellitus Heather Corn, MD, MS Endocrinology, Diabetes, and Metabolism Disclosures Working for Intermountain Healthcare Some of the views represented are the opinion of ABIM-certified
More informationTABLE 1A: Formulary Coverage of Insulin Therapies & Indications for Use in Various Populations
177 TABLE 1A: Formulary Coverage of Insulin Therapies & Indications for Use in Various Populations TABLE 1A : Formulary Coverage of Insulin Therapies & Indications for Use in Various Populations Formulary
More informationWhat s New in Diabetes Medications. Jena Torpin, PharmD
What s New in Diabetes Medications Jena Torpin, PharmD 1 Objectives Discuss new medications in the management of diabetes Understand the mechanism of the medications discussed Understand the side effects
More informationTABLE 1A : Formulary Coverage of Insulin Therapies & Indications for Use in Various Populations
177 TABLE 1A : Formulary Coverage of Insulin Therapies & Indications for Use in Various Populations Formulary Coverage Indication for use with: INSULIN THERAPY NS NB NL PE ADULTS PEDIATRICS PREGNANCY BOLUS
More informationDrug Class Review Newer Diabetes Medications and Combinations
Drug Class Review Newer Diabetes Medications and Combinations Final Update 2 Report July 2016 The purpose reports is to make available information regarding the comparative clinical effectiveness and harms
More informationHealthy You: A Guide to Diabetes Self-Care SURVIVAL SKILLS
Healthy You: A Guide to Diabetes Self-Care SURVIVAL SKILLS Table of Contents Introduction 3 Monitoring Your Diabetes 7 Medications 11 Problem Solving 24 Healthy Eating with Diabetes 26 Managing Sick Days
More informationDIABETES (1 of 5) Generic. Generic $0 $5 $5-10 $0 $0 $0. Generic $0 $5 $5-10. Generic. Generic $0 $5 $5-10 $0 $0 $0. Generic $0 $5 $5-10 $0 $0 $0
Metformin DIABETES (1 of 5) Glucophage Glucophage XR ER $7 (500mg) $7 (500mg) $5 $5 500mg, 750mg only 500mg, 750mg only Sulfonylurea/Combinations Amaryl Glucotrol glimepiride glipizide $5 $5 Glucotrol
More informationPharmacologic Agents for Treatment of Type 2 Diabetes
Pharmacologic Agents for Treatment of Type 2 Diabetes SCAN Drugs Medication Biguanides 1 1 er uncoated tabs 500 mg & 750 mg Sulfonylureas 1 1 500 850 mg QD - TID 500 2000 mg glimepiride 1 1 1 8 mg glipizide
More informationLiving with Diabetes
Living with Diabetes You Are Not Alone! Diabetes continues to grow each year at an alarming rate in the United States. According to the Centers for Disease Control and Prevention (CDC), nearly 30 million
More informationLive Your Life! Control Your Diabetes. La Clínica NAME: LA CLÍNICA FORM 8079 (REV 12/15)
Live Your Life! Control Your Diabetes La Clínica LA CLÍNICA FORM 8079 (REV 12/15) www.laclinica.org NAME: My Results Lab Test Result Date Due/Target A1C Cholesterol Blood Pressure Microalbumin Dilated
More informationPhysician Drug Reference Chart for Diabetes Antidiabetic Medications
Drug Class Compound Brand Name Mechanism of Action Advantages Disadvantages Alpha-glucosidase inhibitors Medium Cost by Bayer Healthcare, Pfizer, Takeda Research Acarbose Miglitol Voglibose Precose Glyset
More informationThe information in this guide comes from a government-funded review of research about pills for type 2 diabetes.
effectivehealthcare.ahrq.gov Pills for Type 2 Diabetes: A Guide for Adults Consumer Summary Guide published 5 Dec 2007 1. Introduction What does this guide cover? Type 2 diabetes means the body has a problem
More informationUpdate on Therapies for Type 2 Diabetes: Angela D. Mazza, DO July 31, 2015
Update on Therapies for Type 2 Diabetes: 2015 Angela D. Mazza, DO July 31, 2015 Objectives To present the newer available therapies for the management of T2D To discuss the advantages and disadvantages
More informationPharmacology. Kacy Aderhold, MSN, APRN-CNS, CMSRN
Pharmacology Kacy Aderhold, MSN, APRN-CNS, CMSRN Biguanides Decreases hepatic glucose production and improves insulin sensitivity (increases number of insulin receptors) Common Adverse Reaction: diarrhea
More informationStaying Healthy With Diabetes
Staying Healthy With Diabetes For: We care. We will listen. We can help. 1 Table of Contents Table of Contents... 2 About Diabetes... 3 Blood Glucose Testing at Home... 4 High and Low Blood Glucose (Sugar)
More informationDM Fundamentals Class 4 Meds for Type 2
DM Fundamentals Class 4 Meds for Type 2 Beverly Thomassian, RN, MPH, BC ADM, CDE President, Diabetes Education Services Copyright 1999 2015, Diabetes Education Services, All Rights Reserved. Diabetes Meds
More informationRhonda Eustice, PharmD, CDE. Will Power lasts about two weeks and is soluble in alcohol. Mark Twain
Rhonda Eustice, PharmD, CDE Will Power lasts about two weeks and is soluble in alcohol. Mark Twain Diabetes Management: The Three Legged Stool Diet Medication Exercise Objectives Know the treatment goals
More informationDiabetes. HED\ED:NS-BL 037-3rd
Diabetes HED\ED:NS-BL 037-3rd Diabetes Diabetes mellitus is an epidemic disease and based on a recent study published on 2011, the estimated number of affected people is 366 million worldwide and the number
More informationType II Diabetes Improving Blood Sugar Control. Geneva Clark Briggs, Pharm.D., BCPS
Type II Diabetes Improving Blood Sugar Control Geneva Clark Briggs, Pharm.D., BCPS Overview Importance of glucose control State of control Review available therapies Helping patients achieve control The
More informationClinical Practice Guidelines
Clinical Practice Guidelines Diabetes Objective The purpose is to guide the appropriate diagnosis and management of Diabetes. This guideline is designed to assist the clinician by providing a framework
More informationCollaborative Practice Agreement
Collaborative Practice Agreement [community pharmacy name] [address] [phone number] [physician practice] [address] [phone number] Effective: [date] Expiration: [date] 1 Table of Contents 1.0 Introduction...4
More informationClinical Pharmacotherapeutic Applications of the American Diabetes Association Standards of Care 2018
Clinical Pharmacotherapeutic Applications of the American Diabetes Association Standards of Care 2018 RACHEL NAIDA, PHARMD, CDE CLINICAL ASSOCIATE PROFESSOR UNIVERSITY OF NEW ENGLAND COLLEGE OF PHARMACY
More informationNew Therapies for Diabetes
Type 2 diabetes is increasingly prevalent New Therapies for Diabetes Lynn Mack, M.D. Associate Professor Diabetes, Endocrinology, & Metabolism The Nebraska Medical Center lmack@unmc.edu No Conflicts of
More informationDM Fundamentals Class 4 Meds for Type 2
DM Fundamentals Class 4 Meds for Type 2 Beverly Thomassian, RN, MPH, BC ADM, CDE President, Diabetes Education Services Copyright 1999 2015, Diabetes Education Services, All Rights Reserved. Diabetes Meds
More informationAdvanced Practice Education Associates. Endocrine
Advanced Practice Education Associates Endocrine Overview Diabetes Thyroid Disease 162 Copyright 2016 Advanced Practice Education Associates DIABETES MELLITUS What is the BMI cut point for screening adults
More informationAntihyperglycemic Agents in Diabetes. Jamie Messenger, PharmD, CPP Department of Family Medicine East Carolina University August 18, 2014
Antihyperglycemic Agents in Diabetes Jamie Messenger, PharmD, CPP Department of Family Medicine East Carolina University August 18, 2014 Objectives Review 2014 ADA Standards of Medical Care in DM as they
More informationEndo 2 SLO Practice (online) Page 1 of 7
Endo 2 SLO Practice (online) Page 1 of 7 1. A long- acting insulin, like Lantus is for? A. When the next meal is within 30-60 minutes of the injection B. Over night use or for ½ of the day often combined
More informationImproving Patient Outcomes with Individualized Therapy in the Management of Type 2 Diabetes
Improving Patient Outcomes with Individualized Therapy in the Management of Type 2 Diabetes Timothy S. Reid, M.D. Mercy Diabetes Center Janesville, WI Duality Statement Dr. Reid is a Speaker and Consultant
More informationDIABETES. Mary Bruskewitz APNP, MS, BC-ADM Clinical Nurse Specialist Diabetes. November 2013
DIABETES Mary Bruskewitz APNP, MS, BC-ADM Clinical Nurse Specialist Diabetes November 2013 mbruskewitz@outlook.com Objectives Part 1 Overview of Endocrine Physiology Pathophysiology of Diabetes Diabetes
More informationSTEP THERAPY CRITERIA
CATEGORY DRUG CLASS BRAND NAME (generic) STEP THERAPY CRITERIA AMYLIN ANALOG: SYMLIN/SYMLINPEN (pramlintide acetate) ANTIDIABETIC AGENTS GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST (GLP-1): ADLYXIN (lixisenatide)
More informationHow to Fight Diabetes and Win. Diabetes. Medications
How to Fight Diabetes and Win Diabetes Medications MEDICATIONS FOR DIABETES According to the American Diabetes Association, 85% of adults diagnosed with diabetes take insulin and/or oral medication to
More informationWayne Gravois, MD August 6, 2017
Wayne Gravois, MD August 6, 2017 Americans with Diabetes (Millions) 40 30 Source: National Diabetes Statistics Report, 2011, 2017 Millions 20 10 0 1980 2009 2015 2007 - $174 Billion 2015 - $245 Billion
More informationWhat You Should Know About Diabetes. Laura Bingell RN Transition Center Nurse for MFP (607)
What You Should Know About Diabetes Laura Bingell RN Transition Center Nurse for MFP (607)962-8225 lbingell@ilny.org Diabetes Mellitus (DM) a group of diseases marked by high blood glucose levels. 9.3%
More information第十五章. Diabetes Mellitus
Diabetes-1/9 第十五章 Diabetes Mellitus 陳曉蓮醫師 2/9 - Diabetes 羅東博愛醫院 Management of Diabetes mellitus A. DEFINITION OF DIABETES MELLITUS Diabetes Mellitus is characterized by chronic hyperglycemia with disturbances
More informationOral and Injectable Medication Options for Diabetes Treatment
Oral and Injectable Medication Options for Diabetes Treatment Presented by: Dr. Daphne E. Smith, Pharm.D., CDE Clinical Assistant Professor/Clinical Pharmacist-University of Illinois at Chicago College
More informationDiabetes: Assessing your risk
Diabetes: Assessing your risk What is diabetes? There are 2 types of diabetes. Type 1 diabetes occurs when the body does not make a hormone called insulin. Insulin helps the body use sugar (also called
More informationDiabetes, Drugs and Dangerous Discrepancies. Sally Bodenhamer, OD, OT/L, CDE
Diabetes, Drugs and Dangerous Discrepancies Sally Bodenhamer, OD, OT/L, CDE I have no disclosures Disclosures $245 BILLION American DM ASSOC 2012 cost of Diabetes Economic Costs of Diabetes in the U.S.
More informationMedications for Diabetes
Medications for Diabetes Sweet, but not too sweet Colette Raymond, Pharm D June 15, 2011 Learning Objectives At the end of this presentation you should be able to: Understand the prevalence and types of
More informationHow they work and when to take them. Diabetes Medications
How they work and when to take them Diabetes Medications BIGUANIDES Metformin Actions Slows down the release of glucose from the liver. Helps the bodies cells become more sensitive to insulin. Pros Weight
More informationAntidiabetic Agents CHAPTER BIGUANIDES
ajt/shutterstock, Inc. CHAPTER 2 Antidiabetic Agents Charles Ruchalski, PharmD, BCPS BIGUANIDES For newly diagnosed patients with type 2 diabetes, the biguanide metformin is the drug of choice for initial
More informationNew Treatments for Type 2 diabetes. Nandini Seevaratnam April 2016 Rushcliffe Patient Forum
New Treatments for Type 2 diabetes Nandini Seevaratnam April 2016 Rushcliffe Patient Forum Overview Growing population of Type 2 diabetes Basic science on what goes wrong Current treatments Why there is
More informationDiabetes Overview. Basics of Diabetes
Diabetes Overview Basics of Diabetes Objectives Review the prevalence of diabetes, how it develops and the risk of developing diabetes Review diabetes diagnosis Identify the key areas of medically managing
More informationThe Many Faces of T2DM in Long-term Care Facilities
The Many Faces of T2DM in Long-term Care Facilities Question #1 Which of the following is a risk factor for increased hypoglycemia in older patients that may suggest the need to relax hyperglycemia treatment
More informationLiving Well With Diabetes A Self-Management Guide
Living Well With Diabetes A Self-Management Guide Table of Contents What is Diabetes?...1 Risk Factors for Diabetes.2 Diagnosis of Diabetes..2 Effects of Diabetes..3 General Healthcare...6 Nutrition Therapy.8
More informationNEW DIABETES CARE MEDICATIONS
NEW DIABETES CARE MEDICATIONS James Bonucchi DO, ECNU, FACE Adult Medicine and Endocrinology Specialists Disclosures Speakers bureau Sanofi AZ BI Diabetes Diabetes cost ADA 2017 data Ever increasing disorder.
More information6/1/2018. Lou Haenel, IV, DO, FACE, FACOI Endocrinology Roper St Francis Charleston, SC THE OMINOUS OCTET: HOW PATHOPHYSIOLOGY AND THERAPY MERGE
Lou Haenel, IV, DO, FACE, FACOI Endocrinology Roper St Francis Charleston, SC THE OMINOUS OCTET: HOW PATHOPHYSIOLOGY AND THERAPY MERGE 1 2 3 Sulfonylureas Glipizide Glyburide Glimeperide 4 Metformin Gold
More information3. Cardiovascular Disease?
Swiss recommendations 2016 Swiss Society of Endocrinology and Diabetology 1. Deficiency? Basal Premixed- Basal + GLP-1 RA (Xultophy ) or Basal Bolus 2. egfr < 30 ml/min? 3. Cardiovascular Disease? 4. Heart
More informationWhat s New on the Horizon: Diabetes Medication Update
What s New on the Horizon: Diabetes Medication Update Outline of Talk Newly released and upcoming medications: the incretins, DPP-IV inhibitors, and what s coming Revised ADA/EASD and AACE guidelines:
More informationThe Death of Sulfonylureas? A Review of New Diabetes Medications
The Death of Sulfonylureas? A Review of New Diabetes Medications Kelly Hoenig, Pharm.D., BCPS Cedar Rapids Family Medicine Residency 2/4/17 Objectives Review GLP-1 Agonists, DPP-IV Inhibitors and SGLT-2
More informationDrug Therapy in Diabetes HEATHER TINGLE UK COLLEGE OF PHARMACY, PY4
Drug Therapy in Diabetes HEATHER TINGLE UK COLLEGE OF PHARMACY, PY4 OVERVIEW Characteristic Type 1 DM (10%) Type 2 DM (90%) Formerly known as Juvenile; Insulin-dependent Adult onset; Non-insulin dependent
More informationLet s not sugarcoat it! Update on Pharmacologic Management of Type II DM
Let s not sugarcoat it! Update on Pharmacologic Management of Type II DM Gregory Castelli, PharmD, BCPS, BC-ADM Clinical Pharmacist UPMC St. Margaret Objectives By the end of this presentation, participants
More informationUnderstanding Your Diabetes: A Basic Guide
Understanding Your Diabetes: A Basic Guide Table of Contents First Steps to Managing Your Diabetes at Home When Your Blood Sugar is Too High (Hyperglycemia) Blood Sugar Targets and Blood Sugar Log How
More informationSide Effects of: GLP-1 agonists DPP-4 inhibitors SGLT-2 inhibitors. Bryce Fukunaga PharmD April 25, 2018
Side Effects of: GLP-1 agonists DPP-4 inhibitors SGLT-2 inhibitors Bryce Fukunaga PharmD April 25, 2018 Objectives For each drug class: Identify the overall place in therapy Explain the mechanism of action
More informationTREATMENTS FOR TYPE 2 DIABETES. Susan Henry Diabetes Specialist Nurse
TREATMENTS FOR TYPE 2 DIABETES Susan Henry Diabetes Specialist Nurse How can we improve outcomes in Type 2 diabetes? Earlier diagnosis Better patient education Stress central role of lifestyle management
More informationAbbreviations DPP-IV dipeptidyl peptidase IV DREAM Diabetes REduction Assessment with ramipril and rosiglitazone
Index Abbreviations DPP-IV dipeptidyl peptidase IV DREAM Diabetes REduction Assessment with ramipril and rosiglitazone Medication GAD glutamic acid decarboxylase GLP-1 glucagon-like peptide 1 NPH neutral
More informationDiabetes Basics - The who, what, why, and how of diabetes care
Diabetes Basics - The who, what, why, and how of diabetes care Garrett Huxall Pharm.D, CGP,FASCP Consultant Pharmacist PharmCare/Deer Creek Consulting Objectives Understand what diabetes is and the complications
More informationCaring for Your Diabetes:
Inova Center for Wellness and Metabolic Health Caring for Your Diabetes: Basic Information to Help You Get Started Locations: Inova Center for Wellness and Metabolic Health Fairfax 2740 Prosperity Avenue,
More informationRebecca Newberry APRN MS CDE
Current Diabetes Medications Nursing Implications and Applications Rebecca Newberry APRN MS CDE Methodist Center for Diabetes and Nutritional Health Disclosures Objectives Speakers Bureaus/Consulting Board
More informationAACE/ACE Consensus Statement American Association of Clinical Endocrinologists and American College of Endocrinology
AACE/ACE Consensus Statement 2017 American Association of Clinical Endocrinologists and American College of Endocrinology Jeff Worrell, Lt Col, USAF (retired) CRNA MSN Why am I here? Metabolic Syndrome
More informationDiabetes Update Bryan Heart Conference September 5, 2015 Shannon Wakeley, MD. Disclosures. Objectives 9/1/2015
Diabetes Update Bryan Heart Conference September 5, 2015 Shannon Wakeley, MD Disclosures I speak on behalf of the following companies: Astra Zeneca, Boehringer Ingelheim, Johnson & Johnson, Sanofi and
More informationcontinuing education for pharmacists
continuing education for pharmacists 2016 AACE/ACE Guidelines on Type 2 Diabetes Management and New Glycemic Control Agents Amanda R. Kriesen, R.Ph., PharmD, and Erin Bastick, R.Ph., PharmD Volume XXXV,
More informationWhat s New on the Horizon: Diabetes Medication Update. Michael Shannon, MD Providence Endocrinology, Olympia WA
What s New on the Horizon: Diabetes Medication Update Michael Shannon, MD Providence Endocrinology, Olympia WA 1 Outline of Talk Newly released and upcoming medications: the incretins, DPP-IV inhibitors,
More informationMedical Nutrition Therapy for Diabetes Mellitus. Raziyeh Shenavar MSc. of Nutrition
Medical Nutrition Therapy for Diabetes Mellitus Raziyeh Shenavar MSc. of Nutrition Diabetes Mellitus A group of diseases characterized by high blood glucose concentrations resulting from defects in insulin
More informationOur Vision NADA BoD Strategic Planning Session -
Who we are NADA is a not-for-profit members-led organization established in 1995 as a result of the rising rates of diabetes among First Nations, Inuit and Métis Peoples in Canada Our Vision - 2016 NADA
More informationDrugs used in Diabetes. Dr Andrew Smith
Drugs used in Diabetes Dr Andrew Smith Plan Introduction Insulin Sensitising Drugs: Metformin Glitazones Insulin Secretagogues: Sulphonylureas Meglitinides Others: Acarbose Incretins Amylin Analogues Damaglifozin
More informationManagement of Diabetes New Concepts New Devices New Medications. Richard J. Comi, MD Professor of Medicine Geisel School of Medicine at Dartmouth
Management of Diabetes New Concepts New Devices New Medications Richard J. Comi, MD Professor of Medicine Geisel School of Medicine at Dartmouth Objectives: At the end of this lecture, the learner will
More informationThe Community Pharmacist s Role in Diabetes Treatment
CONTINUING EDUCATION The Community Pharmacist s Role in Diabetes Treatment By Kimberly Ference, PharmD U pon completion of this activity, the pharmacist should be able to achieve these directives: 1. Describe
More informationWhat s New in Type 2 Diabetes? 2018 Diabetes Updates
What s New in Type 2 Diabetes? 2018 Diabetes Updates Gretchen Ray, PharmD, PhC, BCACP, CDE Associate Professor, UNM College of Pharmacy January 28, 2018 gray@salud.unm.edu OBJECTIVES Describe the most
More information